Effects of different anti-rejection drugs and projects on dyslipidemia after organ transplantation
10.3760/cma.j.issn.1000-6699.2015.09.018
- VernacularTitle:抗器官排斥药物和方案对器官移植术后血脂变化的影响
- Author:
Mengjuan XUE
;
Chaoyang LYU
;
Yao ZHANG
;
Shunmei HE
;
Mingxiang YU
- Publication Type:Journal Article
- Keywords:
Different eras;
Organ transplantation;
Anti-rejection drugs;
Dyslipidemia
- From:
Chinese Journal of Endocrinology and Metabolism
2015;(9):816-818
- CountryChina
- Language:Chinese
-
Abstract:
[Summary] Dyslipidemia after organ transplantation is one of the important risk factors of postoperative cardiovascular disease and graft dysfunction. There are many factors that result in postoperative dyslipidemia. However, the factors influencing serum lipid levels are changing with the development of organ transplantation. In this article the effects of different anti-rejection drugs such as cyclosporine, azathioprine, mycophenolate mofetil, tacrolimus, rapamycin ( sirolimus ) , corticosteroids, and monoclonal antibody on dyslipidemia after organ transplantation were summarized in different eras.
